IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19455

Article Published : 8041

Total Authors : 21252

Total Reviewer : 769

Total Countries : 144

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Evaluation Of Safety Of Azilsartan And Olmesartan In Patients Of Hypertension: Randomized Controlled Trial.
Authors Name: Dr.Deeksha Sharma , Dr Dinesh Kansal , Dr Dhiraj Kapoor , Dr Atal Sood
Download E-Certificate: Download
Author Reg. ID:
IJRTI_187389
Published Paper Id: IJRTI2306144
Published In: Volume 8 Issue 6, June-2023
DOI: https://doi.org/10.56975/ijrti.v8i6.187389
Abstract: Background: Renin‐angiotensin aldosterone system (RAAS) inhibitor either angiotensin‐converting enzyme inhibitor or an angiotensin II receptor blocker (ARB) plus diuretic is a widely used for treatment of hypertension. Objective: To evaluate safety of azilsartan and olmesartan in patients of hypertension. Material and methods: A randomized, prospective, open label, comparative study was carried out in Pharmacology and Medicine department at Dr. R.P.G.M.C. Kangra at Tanda, HP. The study stretched over one year and haemoglobin (Hb), renal function test (RFT), liver function test (LFT), serum electrolytes were monitored at first, third and sixth month. Out of 69 patients, 35 patients in group A were prescribed tablet azilsartan 40 mg/day and 34 patients in group B were prescribed tablet olmesartan 20 mg/day along with chlorthalidone 12.5 mg/day in both the groups. Statistical analysis: Data was presented as mean + SD. Student’s t-test was used for comparing continuous variables between the two groups. P value < 0.05 was considered significant Results: Both the groups had normal range of haemoglobin, renal function test , liver function test and serum electrolyte over 6 months of period. There was no hepatotoxicity, nephrotoxicity, electrolyte imbalance and haematological toxicity observed in patients. Conclusion: Azilsartan and olmesartan were safe in patients of hypertension
Keywords: Azilsartan, Olmesartan, Hypertension, Safety
Cite Article: "Evaluation Of Safety Of Azilsartan And Olmesartan In Patients Of Hypertension: Randomized Controlled Trial.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 6, page no.960 - 967, June-2023, Available :http://www.ijrti.org/papers/IJRTI2306144.pdf
Downloads: 000205244
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2306144
Registration ID:187389
Published In: Volume 8 Issue 6, June-2023
DOI (Digital Object Identifier): https://doi.org/10.56975/ijrti.v8i6.187389
Page No: 960 - 967
Country: kangra, himachal pradesh, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2306144
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2306144
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner